Suzanne Shusterman

3.0k citations

63 papers · 1.7k indexed · h-index 23

Impact in

Neurology top 2%
- Neuroblastoma Research and Treatments
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Neurology 48
- Neuroblastoma Research and Treatments 47
Cancer Research 19
- Cancer, Hypoxia, and Metabolism 17

Co-authors: John M. Maris (18 shared papers)Lisa Diller (9 shared papers)Wendy B. London (13 shared papers)Anna T. Meadows (1 shared paper)Steven G. DuBois (15 shared papers)Julia Glade Bender (8 shared papers)Peter C. Adamson (5 shared papers)Paul M. Sondel (6 shared papers)
Journals: Journal of Clinical Oncology (20 papers)Pediatric Blood & Cancer (5 papers)Clinical Cancer Research (4 papers)Cancer (3 papers)Cancer Medicine (2 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

Suzanne Shusterman

60 papers receiving 1.7k citations

Peers

Countries citing papers authored by Suzanne Shusterman

Since Specialization

Citations

This map shows the geographic impact of Suzanne Shusterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Shusterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Shusterman more than expected).

Fields of papers citing papers by Suzanne Shusterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Shusterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Shusterman. The network helps show where Suzanne Shusterman may publish in the future.

Co-authors

The 25 scholars most cited alongside Suzanne Shusterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne Shusterman Line = papers co-authored together Suzanne Shusterman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study Journal of Clinical Oncology ·Suzanne Shusterman, Wendy B. London, Stephen D. Gillies, Jacquelyn A. Hank, Stephan D. Voss, Robert C. Seeger, C. Patrick Reynolds, Jennifer Kimball, Mark R. Albertini, Barrett Wagner, Jacek Gan, Jens C. Eickhoff, Kenneth B. DeSantes, Susan L. Cohn, Toby T. Hecht, Brian Gadbaw, Ralph A. Reisfeld, John M. Maris, Paul M. Sondel	2010	181
2	Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy Cancer Research ·David Delgado, Jacquelyn A. Hank, Jill Kolesar, David Lorentzen, Jacek Gan, Songwon Seo, KyungMann Kim, Suzanne Shusterman, Stephen D. Gillies, Ralph A. Reisfeld, Richard K. Yang, Brian Gadbaw, Kenneth B. DeSantes, Wendy B. London, Robert C. Seeger, John M. Maris, Paul M. Sondel	2010	136
3	A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma Cancer Immunology Immunotherapy ·Deepa Kolaseri Krishnadas, Suzanne Shusterman, Fanqi Bai, Lisa Diller, Janice E. Sullivan, Alexandra Cheerva, Rani E. George, Kenneth G. Lucas	2015	133
4	Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors JAMA Oncology ·Marian H. Harris, Steven G. DuBois, Julia Glade Bender, AeRang Kim, Brian D. Crompton, Erin Parker, Ian P. Dumont, Andrew L. Hong, Dongjing Guo, Alanna J. Church, Kimberly Stegmaier, Charles W.M. Roberts, Suzanne Shusterman, Wendy B. London, Laura E. MacConaill, Neal I. Lindeman, Lisa Diller, Carlos Rodríguez‐Galindo, Katherine A. Janeway	2016	119
5	Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study Clinical Cancer Research ·Steven G. DuBois, Suzanne Shusterman, Ashish M. Ingle, Charlotte H. Ahern, Joel M. Reid, Bing Wu, Sylvain Baruchel, Julia Glade Bender, Percy Ivy, Holcombe E. Grier, Peter C. Adamson, Susan M. Blaney	2011	96
6	Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium Journal of Clinical Oncology ·Richard Aplenc, Susan M. Blaney, Lewis C. Strauss, Frank M. Balis, Suzanne Shusterman, Ashish M. Ingle, Shruti Agrawal, Junfeng Sun, James R. Wright, Peter C. Adamson	2011	94
7	Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study Journal of Clinical Oncology ·Katherine K. Matthay, Alekist Quach, John P. Huberty, Benjamin L. Franc, Randall A. Hawkins, Hollie Jackson, Susan Groshen, Suzanne Shusterman, Gregory A. Yanik, Janet Veatch, Patricia Brophy, Judith G. Villablanca, John M. Maris	2009	79
8	The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease. PubMed ·Suzanne Shusterman, Stephan A. Grupp, Ronald D. Barr, David Carpentieri, Huaqing Zhao, John M. Maris	2001	77
9	Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study Cancer Chemotherapy and Pharmacology ·Jane E. Minturn, Audrey E. Evans, Judith G. Villablanca, Gregory A. Yanik, Julie R. Park, Suzanne Shusterman, Susan Groshen, Edward T. Hellriegel, Debra M. Bensen-Kennedy, Katherine K. Matthay, Garrett M. Brodeur, John M. Maris	2011	67
10	Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. PubMed ·John M. Maris, Matthew J. Weiss, Yaël P. Mossé, George Hii, Chun Guo, Peter S. White, Michael D. Hogarty, Tamar L. Mirensky, Garrett M. Brodeur, Timothy R. Rebbeck, Margrit Urbanek, Suzanne Shusterman	2002	56
11	Long term survivors of childhood leukemia Current Opinion in Hematology ·Suzanne Shusterman, Anna T. Meadows	2000	50
12	Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors. Journal of Clinical Oncology ·Giles Robinson, Amar Gajjar, Karen Gauvain, Ellen M. Basu, Margaret E. Macy, Luke Maese, Amit J. Sabnis, Jennifer H. Foster, Suzanne Shusterman, Janet Yoon, Brian Weiss, Mohamed S Abdelbaki, Mufiza Farid‐Kapadia, Georgina Meneses‐Lorente, Alison K. Cardenas, Katherine E. Hutchinson, Guillaume Bergthold, Edna Chow Maneval, Elizabeth Fox, Ami V. Desai	2019	41
13	Prospects for therapeutic inhibition of neuroblastoma angiogenesis Cancer Letters ·Suzanne Shusterman, John M. Maris	2005	40
14	Unrealistic parental expectations for cure in poor‐prognosis childhood cancer Cancer ·Jennifer W. Mack, Angel M. Cronin, Hajime Uno, Suzanne Shusterman, Clare J. Twist, Rochelle Bagatell, Abby R. Rosenberg, Araz Marachelian, Meaghan Granger, Julia Glade Bender, Justin N. Baker, Julie Park, Susan L. Cohn, Alyssa Levine, Sarah Taddei, Lisa Diller	2019	38
15	Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer Journal of Pain and Symptom Management ·Jennifer W. Mack, Hajime Uno, Clare J. Twist, Rochelle Bagatell, Abby R. Rosenberg, Araz Marachelian, Meaghan Granger, Julia Glade Bender, Justin N. Baker, Julie R. Park, Susan L. Cohn, Jorge Hernández Fernández, Lisa Diller, Suzanne Shusterman	2020	35
16	Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children’s Oncology Group study Cancer Chemotherapy and Pharmacology ·Steven G. DuBois, Suzanne Shusterman, Joel M. Reid, Ashish M. Ingle, Charlotte H. Ahern, Sylvain Baruchel, Julia Glade Bender, Percy Ivy, Peter C. Adamson, Susan M. Blaney	2011	32
17	Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with Neuroblastoma Clinical Cancer Research ·Stephan A. Grupp, Eline T. Luning Prak, Jean Boyer, Kenyetta R. McDonald, Suzanne Shusterman, Edward W. Thompson, Colleen Callahan, Abbas F. Jawad, Bruce L. Levine, Carl H. June, Kathleen E. Sullivan	2012	31
18	Methionine Aminopeptidase 2 Inhibition Is an Effective Treatment Strategy for Neuroblastoma in Preclinical Models Clinical Cancer Research ·Michael J. Morowitz, Rosalind Barr, Qun Wang, Rebecca L. King, Nicholas Rhodin, Bruce Pawel, Huaqing Zhao, Scott Erickson, George S. Sheppard, Jieyi Wang, John M. Maris, Suzanne Shusterman	2005	29
19	Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors Pediatric Blood & Cancer ·Robin E. Norris, Suzanne Shusterman, Lia Gore, Jodi A. Muscal, Margaret E. Macy, Elizabeth Fox, Noah Berkowitz, Aby Buchbinder, Rochelle Bagatell	2014	28
20	Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study Clinical Cancer Research ·Suzanne Shusterman, Arlene Naranjo, Collin Van Ryn, J. Hank, Marguerite T. Parisi, Barry L. Shulkin, Sabah Servaes, Wendy B. London, Hiroyuki Shimada, Jacek Gan, Stephen D. Gillies, John M. Maris, Julie R. Park, Paul M. Sondel	2019	26

About Suzanne Shusterman

Suzanne Shusterman is a scholar working on Neurology, Cancer Research, Oncology, Genetics and Hematology, having authored 63 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (47 papers), Cancer, Hypoxia, and Metabolism (17 papers), Cancer therapeutics and mechanisms (12 papers), Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers), Childhood Cancer Survivors' Quality of Life (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Neurology (738 citations), Cancer Research (384 citations), Oncology (642 citations), Immunology (343 citations) and Genetics (157 citations). Suzanne Shusterman has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include John M. Maris, Lisa Diller, Wendy B. London, Anna T. Meadows, Steven G. DuBois, Julia Glade Bender, Peter C. Adamson, Paul M. Sondel, Ashish M. Ingle and Susan M. Blaney. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Clinical Cancer Research, Cancer and Cancer Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact